TGFB1 and non-small cell lung carcinoma: More importantly, TGF-β signaling blockade has been shown to decrease Treg cell numbers in a lewis lung carcinoma (LLC) mouse model (75), indicating a potential strategy targeting Treg cells for NSCLC treatment.